Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 3ATOVAQUONE
02 1ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
03 1AVAPRO
04 2BANZEL
05 1BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
06 2BOSULIF
07 1CARBAMAZEPINE
08 1CEFADROXIL
09 1CLARITHROMYCIN
10 1CLEOCIN
11 5CLINDAMYCIN PALMITATE HYDROCHLORIDE
12 8DEFERASIROX
13 1DICLOFENAC SODIUM AND MISOPROSTOL
14 1DISULFIRAM
15 1DUAVEE
16 1EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
17 1ENVARSUS XR
18 3ESOMEPRAZOLE MAGNESIUM
19 1FLO-PRED
20 2GLIMEPIRIDE
21 3IRBESARTAN
22 3IRBESARTAN AND HYDROCHLOROTHIAZIDE
23 1IRBESARTAN; HYDROCHLOROTHIAZIDE
24 1ITRACONAZOLE
25 1JADENU SPRINKLE
26 1LOVASTATIN
27 1MALARONE
28 1MALARONE PEDIATRIC
29 1MEFLOQUINE HYDROCHLORIDE
30 1MEPRON
31 2METHYLPHENIDATE HYDROCHLORIDE
32 2METOPROLOL SUCCINATE
33 1NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
34 1ODOMZO
35 2OXYCODONE HYDROCHLORIDE
36 1PRANDIMET
37 1QUILLIVANT XR
38 1RAPAMUNE
39 2REPAGLINIDE
40 1REPAGLINIDE AND METFORMIN HYDROCHLORIDE
41 2SIROLIMUS
42 2TADALAFIL
43 1TERIL
44 1TRAMADOL HYDROCHLORIDE
45 1VALSARTAN
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Drug : AVAPRO
Dosage Form : TABLET; ORAL
Application Number : 20757
Country : US
Patented : No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
ESOMEPRAZOLE MAGNESIUM; NAPROXEN
Drug : NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 204206
Country : US
Patented : No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : SIROLIMUS
Dosage Form : TABLET; ORAL
Application Number : 201578
Country : US
Patented : No
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 213473
Country : US
Patented : No
